XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
REVENUE:    
Total revenue $ 190 $ 10,660
COSTS AND EXPENSES:    
Research and development 12,217 15,935
General and administrative 9,066 5,583
Total costs and expenses 21,283 21,518
LOSS FROM OPERATIONS (21,093) (10,858)
OTHER (EXPENSE) INCOME, NET:    
Interest income 586 221
Change in fair value of warrant liabilities (63,405) 469
Other expense (26) 31
Total other (expense) income, net (62,845) 721
Net loss $ (83,938) $ (10,137)
Net loss per share attributable to common stockholders-basic (in dollars per share) $ (0.67) $ (0.18)
Net loss per share attributable to common stockholders-diluted (in dollars per share) $ (0.67) $ (0.18)
Weighted-average common stock outstanding-basic (in shares) 125,318,993 56,357,983
Weighted-average common stock outstanding-diluted (in shares) 125,318,993 56,357,983
License    
REVENUE:    
Total revenue   $ 10,660
Research and development services    
REVENUE:    
Total revenue $ 190